Taiwania Capital Management Corporation

At Opsera, we share a vision for the future of software delivery. Our vision is to empower software and DevOps engineers to deliver software faster, safer and smarter by providing them with a continuous orchestration platform that enables choice of any CI/CD tools and no-code automation across the entire DevOps life cycle. Opsera’s continuous orchestration platform provides self-service toolchain automation, drag-and-drop declarative pipelines, and unified insights. With Opsera, development teams can increase software velocity while using the tools they want, operations teams gain improved efficiency while reducing risk and complexity, and business leaders have unparalleled visibility. Opsera believes that DevOps has transformed from an aspiration to a practical science, and its platform is purpose-built to help organizations accelerate DevOps adoption and reach peak innovation velocity.

Syncell is a proteomics technology company focused on enabling targeted protein drug discovery related to specific diseases. The company's innovative Microscoop™ technology allows for microscopy-guided nanoscale protein "scooping," facilitating unbiased subcellular spatial proteomic discovery. This advancement makes it possible to address complex biological problems and identify novel disease biomarkers and druggable targets. Syncell's system transforms a high-content microscope into a precision photolabeling machine, aiding researchers in high-content de novo spatial proteomics to efficiently harvest proteins from selected subcellular locations. Through its technology, Syncell aims to significantly enhance the understanding of diseases and the development of targeted therapies.

Path Robotics, Inc., based in Cleveland, Ohio, specializes in the manufacture of autonomous welding robots. Founded in 2018, the company focuses on designing robotic welding systems that utilize artificial intelligence and machine learning to enhance precision and adaptability in manufacturing processes. These advanced systems automate repetitive welding tasks, helping manufacturers boost productivity while reducing initial costs. By addressing workforce challenges in the manufacturing sector, Path Robotics offers effective automation solutions that streamline operations. Their robots are engineered to autonomously locate and weld seams, significantly reducing production time and improving quality by minimizing errors and inconsistencies. This technology enables industries to simplify their production processes and enhance overall efficiency.

DataPelago specializes in big data analytics solutions, offering a comprehensive platform that integrates both hardware and software products. This platform is designed to extract instantaneous insights from data, regardless of its scale, speed, or structure. By delivering high-performance and cost-effective solutions, DataPelago enables businesses to address complex challenges across various operational layers, enhancing their decision-making capabilities and overall efficiency.

TXOne Networks specializes in cybersecurity solutions aimed at safeguarding industrial control systems from cyber threats. The company develops industrial control systems for industrial IoT environments, such as smart manufacturing, smart cities, and smart energy, to enhance the protection of these critical infrastructures. TXOne Networks provides both network-based and endpoint-based products designed to secure operational technology (OT) networks and mission-critical devices through a real-time, defense-in-depth approach. Their solutions offer comprehensive visibility into ICS assets, protocols, control commands, risks, and threats, ensuring the reliability and safety of various industrial operations.

ARRIS specializes in additive molding technology for creating advanced performance composites tailored for mass-market applications such as aerospace, automotive, and consumer products. The company’s innovative manufacturing process focuses on the precise alignment of continuous carbon fibers, allowing for the integration of electronic components and multifunctional materials into a single, topologically optimized part. This technology enables clients to leverage high-performance composites, enhancing the capabilities and efficiency of their products while meeting the demands of modern manufacturing.

TransferGo is a global money transfer company that provides a cost-effective solution for migrant workers to send money to their families abroad. By employing a digital account-to-account business model, it allows users to transfer funds internationally without incurring unnecessary bank fees. The company operates as a licensed payment institution, ensuring secure transactions under the supervision of relevant financial authorities. TransferGo’s platform enables users to make transfers at significantly lower costs compared to traditional banks and cash bureaus, often with same-day delivery. The service charges a fixed fee for transfers and a currency conversion fee ranging from 0.6% to 1.5%, making it an attractive option for both individuals and businesses looking to pay suppliers internationally.

Daytrip is a platform for traveling with local drivers. It allows independent travelers to get the most out of their vacation by connecting them to local drivers, who drive them from one city to another with their own cars, discovering local sights and culture on the way. It gives travelers an opportunity to see otherwise unreachable countryside sights, meet real locals and get to know local history, culture and current affairs first-hand. Daytrip is an entirely new approach to traveling, combining the comfort of package holidays with the flexibility of independent planning and authenticity of backpacking.

SKY ENGINE AI is a synthetic data cloud generative AI platform for data scientists enabling ai computer vision at scale software allows creating a digital twin of your sensor, drone, or robot and putting them through testing and training in a virtual environment prior to real-world deployment. They are data generation makes data scientist life easier providing perfectly balanced datasets for any computer vision applications like object detection and recognition. They include 3d positioning, pose estimation, and other sophisticated cases including analysis of multi-sensor data radars, lidars, satellites, x-rays, and more.

VRgineers, Inc. is a company that specializes in developing and manufacturing advanced virtual reality solutions aimed primarily at enterprise applications in sectors such as automotive, aerospace, and defense. Founded in 2017 and headquartered in Dover, Delaware, with additional offices in Prague and California, VRgineers has gained recognition for its high-resolution XTAL virtual reality headset, which features OLED displays, leap motion hand tracking, and custom-built lenses with 8K resolution. The company also provides a range of simulator products for pilot training, including portable trainers and customizable classroom simulators that cater to various aircraft types. These solutions enhance pilot training by improving situational awareness and operational efficiency. VRgineers collaborates closely with industry professionals, including military and commercial pilots, and has a client roster that includes notable organizations such as the U.S. Air Force and NASA. By integrating cutting-edge technology with practical applications, VRgineers aims to revolutionize training and prototyping processes across multiple industries.

SURGLASSES is a medical innovative company that develops and markets a range of innovative products for use in medical education and surgical navigation solutions. SURGLASSES has developed its own patented technology in the high-performance surgical system and educational products as well. Our manufacturing company is located in Taichung, Taiwan with CE Mark, ISO-13485, and GMP(good manufacturing practice) certifications and we are manufacturing a series of FDA and CE approved medical equipment and devices, mainly aimed for surgical fields and educational purposes. Our product range gives a versatile, cost-effective alternative to major investments in surgical planning and guided tools. We are committed to achieve a significant share of the International market and developing creative solutions in the field of medical products. Bringing high-end and cutting-edge technology to medical, surgical, clinical, and health systems with innovations to make evolutionary improvements. We commit to meeting the needs of surgeons, physicians, patients, caregivers, educators by continuous R&D. Customers are assured of advanced medical experiences and outcomes with our integrated solutions, innovative products, and services. At Taiwan Main Orthopedic Biotechnology, we aim to be the pioneer that strives to make medical insights and contribute to the development in the field of medical electronics, minimally invasive surgery, intelligent medical informatics, real-time medical data digitization & information visualization, surgical navigation, medical augmented reality (AR) and mixed reality (MR). The Key products are Foresee-X and Caduceus, Foresee-X is the first CE-approved Smart surgical glasses with Augmented Reality technology for visualized medical imaging during surgery. The caduceus is a smart surgical glasses for very accurate spine surgical navigation with 3D Mixed Reality.

At Opsera, we share a vision for the future of software delivery. Our vision is to empower software and DevOps engineers to deliver software faster, safer and smarter by providing them with a continuous orchestration platform that enables choice of any CI/CD tools and no-code automation across the entire DevOps life cycle. Opsera’s continuous orchestration platform provides self-service toolchain automation, drag-and-drop declarative pipelines, and unified insights. With Opsera, development teams can increase software velocity while using the tools they want, operations teams gain improved efficiency while reducing risk and complexity, and business leaders have unparalleled visibility. Opsera believes that DevOps has transformed from an aspiration to a practical science, and its platform is purpose-built to help organizations accelerate DevOps adoption and reach peak innovation velocity.

Flat Medical specializes in developing safety technology solutions aimed at enhancing clinical processes. The company's innovative technology is designed for use during surgical procedures, where it plays a crucial role in detecting and preventing surgical mistakes. By doing so, Flat Medical enables clinical professionals to provide safer treatment options for their patients, thereby improving overall patient safety and care quality.

QT Medical’s technology empowers the patients to take an active role in managing their heart disease. Heart disease is responsible for 1 out of every 4 deaths in the U.S. and is the number 1 killer world-wide. No longer do patients with heart disease have to make long trips to their cardiologists, hospitals, or emergency rooms to get diagnostic, hospital-grade ECG scans. They can now perform these tests from the comfort of their homes or anywhere with an internet connection, allowing peace of mind, saving time, reducing stress, and improving outcomes.

Sensoneo is a provider of advanced smart waste management solutions that assist cities and businesses in managing waste more efficiently and sustainably. The company utilizes proprietary ultrasonic sensors to monitor waste levels in real-time, coupled with sophisticated software that facilitates data-driven decision-making and optimizes waste collection processes. This technology enables significant reductions in waste collection costs, with improvements in operational efficiency and a potential decrease in carbon emissions. Sensoneo's solutions have been implemented in various locations across Europe, North America, South America, the Middle East, Australia, and New Zealand, attracting a diverse range of clients seeking to enhance their waste management practices. By automating the waste lifecycle and promoting eco-friendly initiatives, Sensoneo aims to transform traditional waste management into a more transparent and responsible process.

Ethernovia is focused on creating a sophisticated Ethernet system capable of meeting the increasing bandwidth demands of future automotive technologies. The company's system integrates multiple levels of vehicle networks, allowing for significant advancements in vehicle design and construction. Key features of Ethernovia's solution include autonomous expansions, enhanced security intelligence, and optimized sensor bandwidths, all of which contribute to a unified network. This innovative approach enables clients to effectively transform and develop advanced vehicles, fundamentally changing how automotive systems are architected and built.

Developer of innovative protein degradation drugs designed to treat cancer, neurodegenerative and aging-related diseases. The company develops a drug pipeline, using an AI-enabled platform to discover drug candidates, which target and degrade disease-related proteins, enabling researchers, clinicians, and pharmaceutical companies to access a novel class of drugs that address life-threatening and life-impairing diseases plagued by drug resistance.

3drens is a provider of B2B software services specializing in fleet intelligence solutions for commercial fleet owners. The company operates a data-driven Internet of Vehicles platform that connects businesses to essential logistics services. This platform is designed to assist sectors such as vehicle rentals, logistics, transportation, and automakers in managing their fleets more efficiently. By offering low-cost and effective logistics management solutions, 3drens aims to enhance operational performance for its clients in the commercial fleet industry.

Genialis, Inc. is a computational precision medicine company that specializes in developing a web-based software platform for biological data management and analysis. Founded in 2015 and based in Houston, Texas, the platform provides a suite of visual analytics and bioinformatics tools, facilitating the storage, analysis, and sharing of biological data while ensuring transparency and security. The system automates primary analyses to enhance reproducibility and allows non-computational experts to access advanced downstream analyses. Genialis focuses on unraveling complex biology to identify actionable biomarkers, which aids pharmaceutical companies in developing effective drugs and diagnostics that improve treatment decisions. The company's efforts aim to enhance translational research and clinical development, ultimately benefiting patients and their families.

Light Field Lab is a breakthrough technology startup that builds an innovative holographic ecosystem. It re-creates what optical physics calls a real image for off-screen projected objects by generating a massive number of viewing angles that correctly change with the point of view and location just like in the real world. They enable entirely new business opportunities across consumer and enterprise markets. The company was founded in 2017 by Jon Karafin, Brendan Bevensee, and Ed Ibe, with the single mission to enable a holographic future by building upon the founders’ collective expertise of light field technology innovation. Based in San Jose, CA, Light Field Lab is backed by top-tier venture firms including Khosla Ventures.

Oxipit is a developer of artificial intelligence tools focused on enhancing medical imaging, particularly in the field of radiology. The company's primary offering is an AI-based chest X-ray radiology suite that automates the diagnosis and reporting process. This platform efficiently identifies healthy chest X-ray images and generates preliminary reports only when it is highly confident in the findings. By leveraging advancements in AI and machine learning, Oxipit aims to address the global shortage of radiologists and improve the overall quality of diagnostics. This innovation allows medical specialists to concentrate on cases that require further attention, ultimately contributing to better patient outcomes worldwide.

Brightpick offers AI robots for warehouses to easily automate every step of their order fulfillment. The innovative Brightpick robots enable warehouses of any size to fully automate order picking, consolidation and dispatch, as well as stock replenishment. Brightpick Autopicker, the company’s award-winning flagship robot, is the only mobile robot in the world that robotically picks and consolidates orders directly in warehouse aisles. The Brightpick solution takes just weeks to deploy and allows companies to reduce their fulfillment labor to a minimum. Headquartered near Cincinnati, OH, Brightpick has more than 200 employees and hundreds of AI robots deployed across the US and Europe.

Artilux specializes in the development of innovative technology solutions focused on optical connectivity and 3D time of flight (ToF) applications. The company offers a range of integrated circuit (IC) solutions that deliver high performance at competitive costs, catering to both short-range applications, such as consumer electronics with 10-40G capabilities, and long-range data center links with 100G performance. Artilux is also recognized for its discovery of GeSi, a groundbreaking 3D photosensitive material, which is poised to enhance the functionality of next-generation mobile devices. By incorporating advanced optical and radio frequency technologies, Artilux enables seamless data transfer for various applications, from everyday consumer use to complex cloud-based systems.

Litilit specializes in the development of ultra-short pulse lasers, offering advanced technology designed to meet the needs of the industrial laser market. Utilizing a patented laser pulse generator, Litilit achieves telecom-grade performance characterized by high reliability and scalability at competitive prices. The company's innovative femtosecond and self-starting laser technologies have proven to be effective across various industries, including medical equipment, bioimaging, consumer electronics, advanced manufacturing, 3D printing, and laser surgery. By leveraging its in-house expertise, Litilit provides tailored engineering solutions that deliver significant value to clients. This strategic approach positions the company as a leader in the next generation of laser technology, addressing the evolving demands of diverse sectors.

3nets, Inc. is a Santa Clara, CA-based MultiCloud Networking (MCN) company engaged in delivering an applications-aware elastic network infrastructure platform (Network Fabric) that uniquely serves the application delivery needs of enterprises interfacing with Application Fabric (AppFabric). The software-defined Cloud-native WAN platform leverage commercially available hardware owned by the customer and public cloud compute infrastructure along with public/private networks to deliver the applications at a multi-cloud scale. Customers may express intent (or requirements) via a controller which signals the software functions to deliver the services meeting the requirements.

DataPelago specializes in big data analytics solutions, offering a comprehensive platform that integrates both hardware and software products. This platform is designed to extract instantaneous insights from data, regardless of its scale, speed, or structure. By delivering high-performance and cost-effective solutions, DataPelago enables businesses to address complex challenges across various operational layers, enhancing their decision-making capabilities and overall efficiency.

Nanolive SA was incorporated in November 2013 at the EPFL Innovation Park in Lausanne, Switzerland, by Dr. Yann Cotte (CEO) and Dr. Fatih Toy (scientific advisor), following the completion of their respective PhD theses at the EPFL Microsystems laboratory of Prof. Christian Depeursinge (Head of Scientific Advisory Board).

Cognito Health improves the healthcare environment by increasing value for patients and healthcare systems. They continuously monitor patients using predictive algorithms to inform their staff about potential bed exits and repositioning needs.

Fractyl Health, based in Lexington, Massachusetts, specializes in developing innovative medical device solutions for metabolic diseases, particularly type 2 diabetes and obesity. The company’s primary offering, Revita DMR, is a minimally invasive therapy that utilizes hydrothermal ablation to rejuvenate the duodenal lining, which can become compromised due to high-fat and high-sugar diets. By focusing on durable disease-modifying therapies rather than just symptomatic management, Fractyl Health aims to address the underlying causes of metabolic diseases, improving patient outcomes and reducing healthcare burdens. Founded in 2010 and originally named MedCatalyst, Inc., the company envisions a future where less invasive, device-based therapies provide effective solutions for large populations affected by metabolic disorders.

EirGenix Inc., health is important for all people. Under this belief, EirGenix established two business units to achieve the goal. One is contract development and manufacturing operation unit where EirGenix helps clients to manufacture their biologics; the other is the product development operation unit where they hope to fully apply their team's experience and knowledge on biologics from biosimilars, biobetters to new drugs. EirGenix's goal is that every patient can afford high-quality biopharmaceutical drugs.

AmMax is a clinical-stage company that uses translational and clinical development to build a strong oncology portfolio focused on sizeable market opportunities through licensing and partnerships. It unlocks the therapeutic service's potential on the CSF1R platform.

Frequency Therapeutics is a clinical-stage biotechnology company based in Woburn, Massachusetts, that aims to repair or reverse damage from various degenerative diseases by utilizing the body’s own biological mechanisms. The company employs a Progenitor Cell Activation approach, which involves the use of small molecules to activate progenitor cells and promote the regeneration of functional tissue. Its leading product candidate, FX-322, is currently undergoing phase 2a clinical trials to address the underlying causes of sensorineural hearing loss. In addition to hearing loss, Frequency Therapeutics is also exploring treatments for a range of other conditions, including multiple sclerosis and diseases affecting muscle, the gastrointestinal tract, skin, and bone. The company has established a collaboration with Astellas Pharma for the development and commercialization of FX-322. Founded in 2014, Frequency Therapeutics focuses on disease modification without the complexities associated with genetic engineering.

C4 Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapeutic candidates that target and eliminate disease-causing proteins, primarily for the treatment of cancer and neurodegenerative disorders. The company's lead product candidate, CFT7455, is an orally bioavailable degrader designed to target IKZF1/3 for multiple myeloma and other lymphomas. Additionally, C4 is advancing CFT8634, which targets BRD9 for specific solid tumors, alongside programs aimed at genetically defined resistant solid tumors. C4 Therapeutics utilizes its proprietary Degronimid platform, which allows for the selective degradation of proteins through the natural ubiquitin/proteasome system, potentially addressing previously undruggable targets while minimizing drug resistance. The company has formed strategic collaborations with major industry players, and it aims to make a significant impact on the treatment landscape through its advanced protein degradation science and multiple development programs. Founded in 2015 and headquartered in Watertown, Massachusetts, C4 Therapeutics continues to innovate in the field of targeted therapy.

AIxMed helps pathologists to digitize 3D cytology samples in minutes and extract clinical insights in seconds. The company was founded in 2018 and is headquartered in Santa Clara, California, United States.

SyneuRx International Taiwan is a biomedical company focused on developing treatments for central nervous system-related disorders, specifically schizophrenia, depression, and dementia. The company is engaged in the clinical development of several drug candidates, including SND-11, SND-12, and SND-13, with SND-13 currently in Phase IIb/III trials aimed at providing add-on therapy for schizophrenia. Through its research and development efforts, SyneuRx aims to address the significant unmet needs in mental health care, contributing to improved treatment options for patients suffering from these conditions.

TFBS Bioscience is a Contract Research Organization based in Taiwan that offers a variety of biological testing services. The company specializes in viral vector manufacturing for cell and gene therapy products, along with biosafety testing and product release testing for these therapies, vaccines, and other biologic products. Additionally, TFBS Bioscience provides cell bank characterization, viral clearance, bulk and lot release testing, assay development both in vitro and in vivo, clinical sample analysis, and cleaning validation for reusable medical devices. Through its comprehensive service offerings, TFBS Bioscience supports the advancement of biopharmaceutical development and ensures compliance with safety standards.

FaceHeart is a developer of advanced image processing technology that enables the rapid assessment of vital signs through facial video analysis. Its flagship product, FaceHeart Vitals, captures six key vital signs in just 45 seconds without the need for physical contact. This innovative solution can be seamlessly integrated into devices equipped with cameras, making it suitable for a variety of applications in telehealth, elderly care, wellness, and childcare. By leveraging artificial intelligence and deep learning, FaceHeart aims to provide real-time physiological information and enhance understanding of users' health, contributing to a safer and healthier living environment in various sectors, including medical treatment and transportation.

Bigfoot Biomedical, Inc. is a healthcare company focused on improving diabetes management for individuals with Type 1 Diabetes. Established in 2014 and based in Milpitas, California, the company develops an advanced diabetes management system that integrates automated insulin delivery with cloud connectivity and user-friendly automation. This system aims to optimize insulin dosing and delivery through a cohesive ecosystem of medical devices, including an automated infusion pump and a connected insulin pen. Leveraging machine learning and secure consumer technologies, Bigfoot Biomedical provides a comprehensive digital platform that addresses the cognitive, emotional, and financial challenges associated with diabetes management. The company's innovative approach includes a first-of-its-kind monthly subscription service model, making diabetes care more accessible and efficient for patients.

Regenacy Pharmaceuticals, LLC is a biopharmaceutical company based in Boston, Massachusetts, founded in 2016. The company focuses on developing innovative treatments for peripheral neuropathies, hemoglobinopathies, and certain oncology indications. Its approach centers on the regeneration of normal protein function through the use of oral, isoform-selective histone deacetylase (HDAC) inhibitors. Notably, Regenacy is advancing the selective HDAC6 inhibitor ricolinostat, which has potential applications in treating sickle cell disease and beta-thalassemia. Through its novel, disease-modifying strategies, Regenacy aims to address significant unmet medical needs in these therapeutic areas.

Xgene Pharmaceutical Inc. is a late-clinical stage pharmaceutical company established in 2015, based in the Cayman Islands. It focuses on developing small-molecule drugs aimed at treating chronic pain, infectious diseases, and tumors. Utilizing proprietary linker technology, Xgene creates novel, multimodal conjugated molecules that enhance the efficacy and tolerability of pain medications. The company's current programs are dedicated to addressing unmet needs in neurological disorders, making significant strides in the development of innovative treatments for these conditions.

Point Robotics Medtech is an orthopedic and spine robot that optimizes clinical outcomes for patients and physicians. The company received FDA clearance for its Kinguide Robotic-Assisted Surgical System, a handheld robot that can be used in orthopedic surgeries.

Light Field Lab is a breakthrough technology startup that builds an innovative holographic ecosystem. It re-creates what optical physics calls a real image for off-screen projected objects by generating a massive number of viewing angles that correctly change with the point of view and location just like in the real world. They enable entirely new business opportunities across consumer and enterprise markets. The company was founded in 2017 by Jon Karafin, Brendan Bevensee, and Ed Ibe, with the single mission to enable a holographic future by building upon the founders’ collective expertise of light field technology innovation. Based in San Jose, CA, Light Field Lab is backed by top-tier venture firms including Khosla Ventures.

AESOP’s vision is to improve quality, safety and efficiency of healthcare systems through a new paradigm in clinical decision support we call “Deep Clinical Decision Support”. This paradigm involves providing physicians with intelligent workflow support that enables them to seamlessly understand best practice for the full range of diseases, medications and procedures in every clinical context. This can only be enabled through data mining on large sets of structured and unstructured clinical data, and with deep integration into a the clinical systems needed to provide the appropriate workflow support.

Figur8, Inc. is a Boston-based company that specializes in developing advanced wearable sensors to monitor body movement as a biomarker for musculoskeletal (MSK) conditions. Founded in 2016 as a spin-off from MIT, Figur8 combines smart biosensors, intuitive software, and artificial intelligence to analyze MSK health data. The technology captures three-dimensional skeletal movement and muscle output, allowing for objective assessment of musculoskeletal performance and recovery. This innovative solution provides valuable insights throughout the entire care process, from injury to full recovery, ultimately reducing healthcare costs, improving access to treatment, and empowering patients to manage their own MSK health effectively.

Verana Networks, Inc., founded in 2019 and located in Waltham, Massachusetts, specializes in developing innovative 5G Radio Access Network solutions for service providers utilizing licensed millimeter wave (mmWave) spectrum. The company focuses on this spectrum due to its potential for significant expansion in speed and capacity, essential for the successful deployment of 5G technology. Verana's equipment aims to provide gigabit wireless connectivity, enabling mobile network operators to offer enhanced 5G services such as fixed wireless access. By delivering faster speeds and increased capacity, the company supports the creation of new applications that drive incremental revenue, which is crucial for sustaining the business case for 5G.

Nanolive SA was incorporated in November 2013 at the EPFL Innovation Park in Lausanne, Switzerland, by Dr. Yann Cotte (CEO) and Dr. Fatih Toy (scientific advisor), following the completion of their respective PhD theses at the EPFL Microsystems laboratory of Prof. Christian Depeursinge (Head of Scientific Advisory Board).

Light Field Lab is a breakthrough technology startup that builds an innovative holographic ecosystem. It re-creates what optical physics calls a real image for off-screen projected objects by generating a massive number of viewing angles that correctly change with the point of view and location just like in the real world. They enable entirely new business opportunities across consumer and enterprise markets. The company was founded in 2017 by Jon Karafin, Brendan Bevensee, and Ed Ibe, with the single mission to enable a holographic future by building upon the founders’ collective expertise of light field technology innovation. Based in San Jose, CA, Light Field Lab is backed by top-tier venture firms including Khosla Ventures.

Canner is a provider of data management solutions that enables businesses to navigate the complexities of data and its context effectively. The company has developed a universal semantic layer powered by artificial intelligence, which harmonizes various aspects of data, including schema, structure, relationships, and metadata. This innovative solution fundamentally transforms how organizations interact with their data. Canner's flagship offerings include Canner Enterprise, an enterprise-grade semantic layer, and WrenAI, an open-source AI agent and semantic framework. Additionally, Canner offers a content management system that facilitates the management, auditing, analysis, and sharing of data within a unified platform, providing clients with a consolidated view of their data across the organization.

URSROBOT Inc is a leading company specializing in service robotic solutions, dedicated to bringing outdoor service robots into various aspects of daily life. With NEXMOW, we built up the robotic lawnmower solution for commercial landscaping industry. This revolutionary device combines precise outdoor navigation, AI path planning and cloud services, setting smart working way in commercial landscaping industry. With NEXMOW "drop, mow & go" solution, it can help redeploy labors and create productivities.

Pavilion Data Systems Inc. is a technology company that specializes in designing and developing NVMe-over-Fabric storage platforms tailored for massively-parallel applications. Established in 2011 and headquartered in San Jose, California, with additional offices in the Netherlands and India, the company aims to enhance storage performance and efficiency for various sectors, including financial services, government, cloud service providers, and media and entertainment. Pavilion's innovative architecture offers a new category of storage solutions known as Hyperparallel Flash Arrays, which utilize multiple controllers to achieve ultra-low latency and linear scalability, surpassing the limitations of traditional all-flash arrays. The company's offerings include the Pavilion Data OS, which supports Internet and SaaS businesses in delivering critical applications, alongside its OPENCHOICE model that redefines storage procurement and deployment strategies. Through its advanced technology and experienced team, Pavilion Data Systems is positioned as a leader in the evolving landscape of enterprise storage solutions.

WindGap Medical is a biotech company that manufactures medical devices used to treat patients with severe allergies. The company develops auto-injectors that are filled with heat-stable epinephrine that enable physicians to inject it into a patient suffering from anaphylaxis due to an acute allergy attack. The company was established in 2011 and is headquartered in Somerville, Massachusetts.

Appaegis simplifies enterprise data access while enforcing strong zero-trust security for remote access. Its patent-pending solution protects data access and gives administrators full control over how enterprise data is used. The company was founded by security veterans with successful security track records.

LandingAI empowers customers to harness the business value of AI by providing enablement tools and transformation programs. One of the company’s core products is LandingLens, an end-to-end AI platform specifically designed for industrial customers to build, deploy and scale AI-powered visual inspection solutions. Founded by one of the most recognizable names in AI, Dr. Andrew Ng, (founding lead of the Google Brain team and former Chief Scientist at Baidu), and a world class team, LandingAI is uniquely positioned to help companies across the globe successfully move their AI projects from proof-of-concept to full-scale production. Additional information is available at: www.landing.ai.

Pavilion Data Systems Inc. is a technology company that specializes in designing and developing NVMe-over-Fabric storage platforms tailored for massively-parallel applications. Established in 2011 and headquartered in San Jose, California, with additional offices in the Netherlands and India, the company aims to enhance storage performance and efficiency for various sectors, including financial services, government, cloud service providers, and media and entertainment. Pavilion's innovative architecture offers a new category of storage solutions known as Hyperparallel Flash Arrays, which utilize multiple controllers to achieve ultra-low latency and linear scalability, surpassing the limitations of traditional all-flash arrays. The company's offerings include the Pavilion Data OS, which supports Internet and SaaS businesses in delivering critical applications, alongside its OPENCHOICE model that redefines storage procurement and deployment strategies. Through its advanced technology and experienced team, Pavilion Data Systems is positioned as a leader in the evolving landscape of enterprise storage solutions.

Ethernovia is focused on creating a sophisticated Ethernet system capable of meeting the increasing bandwidth demands of future automotive technologies. The company's system integrates multiple levels of vehicle networks, allowing for significant advancements in vehicle design and construction. Key features of Ethernovia's solution include autonomous expansions, enhanced security intelligence, and optimized sensor bandwidths, all of which contribute to a unified network. This innovative approach enables clients to effectively transform and develop advanced vehicles, fundamentally changing how automotive systems are architected and built.

Elixiron Immunotherapeutics is driven by an international team with a shared vision to produce next-generation immunotherapies. This vision drives our mission to target rare and inflammatory disorders as well as cancer for indications that could substantially benefit from advances in immunotherapy approaches. We employ advances in translational medicine to identify targets from clinical observations, and various drug modalities including biologics derived from a proprietary human antibody domain phage display library and a single human B cell antibody cloning platform to develop innovative therapies. Our two lead pipeline candidates are in phase 1 clinical trials. EI-1071, a small molecule inhibitor of CSF-1R kinase activity, is being explored as a potential therapy for Alzheimer's disease as well as tenosynovial giant cell tumors, and a monoclonal antibody, EI-001 is being developed for the treatment of vitiligo and other immunological disorders.

AEye, Inc. develops advanced vision hardware, software, and algorithms for autonomous vehicles and driver-assistance systems. Based in Dublin, California, the company offers a range of products including the 4Sight Intelligent Sensing Platform, which integrates solid-state lidar with low-light cameras and artificial intelligence to provide precise and reliable perception of surroundings. AEye's unique software-defined lidar solutions are designed for dynamic applications in vehicle autonomy, smart infrastructure, and logistics, focusing on delivering faster and more accurate information. The company's notable products include the 4Sight A and 4Sight M sensors, as well as the AE100 and AE200 robotic perception systems, which cater to the mobility market. AEye operates globally, with offices in Germany, Korea, and the United States, and primarily generates revenue from customers in the United States, followed by Europe and the Asia-Pacific region.

SafeLiShare makes it easy and safe to unlock new business models based on the sensitive and private data and programs that you own and generate.

KDAN specializes in AI-driven workflow and data solutions that enhance operational efficiency and organizational agility. The company offers a range of digital tools, including document management and e-signature services, to support business growth and decision-making.

Figur8, Inc. is a Boston-based company that specializes in developing advanced wearable sensors to monitor body movement as a biomarker for musculoskeletal (MSK) conditions. Founded in 2016 as a spin-off from MIT, Figur8 combines smart biosensors, intuitive software, and artificial intelligence to analyze MSK health data. The technology captures three-dimensional skeletal movement and muscle output, allowing for objective assessment of musculoskeletal performance and recovery. This innovative solution provides valuable insights throughout the entire care process, from injury to full recovery, ultimately reducing healthcare costs, improving access to treatment, and empowering patients to manage their own MSK health effectively.

Cognito Health improves the healthcare environment by increasing value for patients and healthcare systems. They continuously monitor patients using predictive algorithms to inform their staff about potential bed exits and repositioning needs.

ARRIS specializes in additive molding technology for creating advanced performance composites tailored for mass-market applications such as aerospace, automotive, and consumer products. The company’s innovative manufacturing process focuses on the precise alignment of continuous carbon fibers, allowing for the integration of electronic components and multifunctional materials into a single, topologically optimized part. This technology enables clients to leverage high-performance composites, enhancing the capabilities and efficiency of their products while meeting the demands of modern manufacturing.

Oculii develops advanced AI software for radar systems, aiming to enhance resolution, range, and accuracy while reducing costs compared to traditional solutions. Its technology is essential for the advancement of autonomous vehicles, which require reliable and high-performance perception capabilities in all weather conditions. By utilizing Virtual Aperture Imaging, Oculii's software allows existing radar hardware to achieve higher angular resolution without the need for increased physical antenna count. This innovation enables the extraction of detailed 4D positioning information from low-cost, off-the-shelf radar components, paving the way for improved radar imaging. Oculii collaborates with leading companies in autonomous vehicles, robotics, and drones, positioning itself as a key player in the development of affordable and effective perception technologies for the future of autonomy.

Touché Solutions, previously known as Mechavision, specializes in the development of robotic technology platforms, particularly focusing on IoT sensor modules and smart manufacturing applications. The company manufactures robot sensor modules and offers advanced plug-in robot haptic technology products, which have been integrated into Qisda's human-machine collaboration production line. Through its commitment to research and development, Touché Solutions aims to enhance the efficiency of intelligent robotic development for its clients, thereby advancing the capabilities of robotics in various industrial applications.

Ubiik is a company specializing in Advanced Metering Infrastructure (AMI) and private LTE (pLTE) solutions, utilizing its proprietary Weightless™ and cellular IoT LPWAN technologies. Established in 2016, Ubiik initially focused on providing Weightless™ LPWAN technology, which is an open standard communication protocol particularly effective for private AMI deployments. Following a successful AMI project in 2018, the company expanded its offerings to include a Platform as a Service (PaaS) solution, establishing itself as a vertical IoT solutions provider. Ubiik has diversified its connectivity solutions to incorporate LTE technologies, addressing the growing demands of the IoT market, particularly for applications requiring robust security compliant with 3GPP standards. Additionally, Ubiik manufactures low-power wireless devices that connect numerous devices to a single base station, enabling users to create tailored solutions for various applications.

AEye, Inc. develops advanced vision hardware, software, and algorithms for autonomous vehicles and driver-assistance systems. Based in Dublin, California, the company offers a range of products including the 4Sight Intelligent Sensing Platform, which integrates solid-state lidar with low-light cameras and artificial intelligence to provide precise and reliable perception of surroundings. AEye's unique software-defined lidar solutions are designed for dynamic applications in vehicle autonomy, smart infrastructure, and logistics, focusing on delivering faster and more accurate information. The company's notable products include the 4Sight A and 4Sight M sensors, as well as the AE100 and AE200 robotic perception systems, which cater to the mobility market. AEye operates globally, with offices in Germany, Korea, and the United States, and primarily generates revenue from customers in the United States, followed by Europe and the Asia-Pacific region.

Tripresso is an online travel agent based in Taipei, Taiwan, established in 2013. Initially, it focused on creating an online marketplace for package tour suppliers, such as Lions Travel and Richmond, while also developing a user-friendly search engine for customers to find suitable travel products. Over time, Tripresso expanded its offerings to include hotels, flight tickets, and customized travel plans for outbound travel. In 2018, the company introduced TripSaaS, a proprietary software-as-a-service system designed to assist traditional travel agencies in managing their websites, product listings, orders, and customer relationships, thereby improving operational efficiency. By leveraging data and partnerships from both online and offline sources, Tripresso aims to streamline travel planning and provide users with affordable travel packages.

Mammoth Cyber specializes in computer and network security, offering an agentless zero-trust access system aimed at securing remote, data, and web access. The company's innovative technology effectively blocks attacks from zero-day exploits, ensuring that enterprise data remains protected within its secure access service edge framework. This solution is adaptable to various architectures, platforms, and existing product portfolios, allowing clients to maintain comprehensive visibility and control over user interactions with applications.

Dcard is a social networking platform founded in 2015 and based in Taipei, Taiwan. It serves as the largest anonymous communication platform in the country, specifically designed to connect students within the campus community. Dcard allows users to share ideas and experiences freely, fostering a comfortable and trustworthy environment for interaction. The platform emphasizes inclusivity, enabling individuals from diverse backgrounds, ages, and interests to participate in discussions and exchanges without the constraints of identity.

Viracta Therapeutics, Inc. is a clinical-stage drug development company based in Cardiff, California, focused on precision oncology for virus-associated malignancies. The company specializes in a viral activation therapy platform aimed at treating cancers linked to the Epstein-Barr Virus (EBV) and other virus-associated diseases. Its lead investigational drug, nanatinostat, is being evaluated in combination with the antiviral valganciclovir in Phase 2 clinical trials for EBV-positive lymphoma, including conditions such as post-transplant lymphoproliferative disorder and plasmablastic lymphoma. Viracta is also exploring the application of this therapeutic approach in treating other EBV-related malignancies, such as nasopharyngeal carcinoma and gastric carcinoma. Founded in 2007 and previously known as HemaQuest Pharmaceuticals, Viracta Therapeutics continues to advance its mission to develop innovative treatments for serious viral-associated cancers.

Ambiq Micro, Inc. specializes in the development of ultra-low power integrated circuits tailored for power-sensitive applications. The company focuses on creating subthreshold power optimized technology, producing real-time clocks and microcontrollers for various uses, including wearables, smart cards, wireless sensors, and Internet-of-Things (IoT) devices. Founded in 2009 and based in Austin, Texas, Ambiq Micro also maintains offices in San Jose, California, and several locations in China. Its pioneering technology aims to facilitate the creation of next-generation wireless electronics by enabling innovative companies to design products that minimize battery dependency, reduce overall power consumption, and enhance design flexibility. Additionally, Ambiq Micro provides technical support services to its clients, further contributing to its mission of advancing low-power semiconductor solutions.

Artilux specializes in the development of innovative technology solutions focused on optical connectivity and 3D time of flight (ToF) applications. The company offers a range of integrated circuit (IC) solutions that deliver high performance at competitive costs, catering to both short-range applications, such as consumer electronics with 10-40G capabilities, and long-range data center links with 100G performance. Artilux is also recognized for its discovery of GeSi, a groundbreaking 3D photosensitive material, which is poised to enhance the functionality of next-generation mobile devices. By incorporating advanced optical and radio frequency technologies, Artilux enables seamless data transfer for various applications, from everyday consumer use to complex cloud-based systems.

C4 Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapeutic candidates that target and eliminate disease-causing proteins, primarily for the treatment of cancer and neurodegenerative disorders. The company's lead product candidate, CFT7455, is an orally bioavailable degrader designed to target IKZF1/3 for multiple myeloma and other lymphomas. Additionally, C4 is advancing CFT8634, which targets BRD9 for specific solid tumors, alongside programs aimed at genetically defined resistant solid tumors. C4 Therapeutics utilizes its proprietary Degronimid platform, which allows for the selective degradation of proteins through the natural ubiquitin/proteasome system, potentially addressing previously undruggable targets while minimizing drug resistance. The company has formed strategic collaborations with major industry players, and it aims to make a significant impact on the treatment landscape through its advanced protein degradation science and multiple development programs. Founded in 2015 and headquartered in Watertown, Massachusetts, C4 Therapeutics continues to innovate in the field of targeted therapy.

Pavilion Data Systems Inc. is a technology company that specializes in designing and developing NVMe-over-Fabric storage platforms tailored for massively-parallel applications. Established in 2011 and headquartered in San Jose, California, with additional offices in the Netherlands and India, the company aims to enhance storage performance and efficiency for various sectors, including financial services, government, cloud service providers, and media and entertainment. Pavilion's innovative architecture offers a new category of storage solutions known as Hyperparallel Flash Arrays, which utilize multiple controllers to achieve ultra-low latency and linear scalability, surpassing the limitations of traditional all-flash arrays. The company's offerings include the Pavilion Data OS, which supports Internet and SaaS businesses in delivering critical applications, alongside its OPENCHOICE model that redefines storage procurement and deployment strategies. Through its advanced technology and experienced team, Pavilion Data Systems is positioned as a leader in the evolving landscape of enterprise storage solutions.

EirGenix Inc., health is important for all people. Under this belief, EirGenix established two business units to achieve the goal. One is contract development and manufacturing operation unit where EirGenix helps clients to manufacture their biologics; the other is the product development operation unit where they hope to fully apply their team's experience and knowledge on biologics from biosimilars, biobetters to new drugs. EirGenix's goal is that every patient can afford high-quality biopharmaceutical drugs.

ARRIS specializes in additive molding technology for creating advanced performance composites tailored for mass-market applications such as aerospace, automotive, and consumer products. The company’s innovative manufacturing process focuses on the precise alignment of continuous carbon fibers, allowing for the integration of electronic components and multifunctional materials into a single, topologically optimized part. This technology enables clients to leverage high-performance composites, enhancing the capabilities and efficiency of their products while meeting the demands of modern manufacturing.

Regenacy Pharmaceuticals, LLC is a biopharmaceutical company based in Boston, Massachusetts, founded in 2016. The company focuses on developing innovative treatments for peripheral neuropathies, hemoglobinopathies, and certain oncology indications. Its approach centers on the regeneration of normal protein function through the use of oral, isoform-selective histone deacetylase (HDAC) inhibitors. Notably, Regenacy is advancing the selective HDAC6 inhibitor ricolinostat, which has potential applications in treating sickle cell disease and beta-thalassemia. Through its novel, disease-modifying strategies, Regenacy aims to address significant unmet medical needs in these therapeutic areas.

LandingAI empowers customers to harness the business value of AI by providing enablement tools and transformation programs. One of the company’s core products is LandingLens, an end-to-end AI platform specifically designed for industrial customers to build, deploy and scale AI-powered visual inspection solutions. Founded by one of the most recognizable names in AI, Dr. Andrew Ng, (founding lead of the Google Brain team and former Chief Scientist at Baidu), and a world class team, LandingAI is uniquely positioned to help companies across the globe successfully move their AI projects from proof-of-concept to full-scale production. Additional information is available at: www.landing.ai.

AEye, Inc. develops advanced vision hardware, software, and algorithms for autonomous vehicles and driver-assistance systems. Based in Dublin, California, the company offers a range of products including the 4Sight Intelligent Sensing Platform, which integrates solid-state lidar with low-light cameras and artificial intelligence to provide precise and reliable perception of surroundings. AEye's unique software-defined lidar solutions are designed for dynamic applications in vehicle autonomy, smart infrastructure, and logistics, focusing on delivering faster and more accurate information. The company's notable products include the 4Sight A and 4Sight M sensors, as well as the AE100 and AE200 robotic perception systems, which cater to the mobility market. AEye operates globally, with offices in Germany, Korea, and the United States, and primarily generates revenue from customers in the United States, followed by Europe and the Asia-Pacific region.

Ambiq Micro, Inc. specializes in the development of ultra-low power integrated circuits tailored for power-sensitive applications. The company focuses on creating subthreshold power optimized technology, producing real-time clocks and microcontrollers for various uses, including wearables, smart cards, wireless sensors, and Internet-of-Things (IoT) devices. Founded in 2009 and based in Austin, Texas, Ambiq Micro also maintains offices in San Jose, California, and several locations in China. Its pioneering technology aims to facilitate the creation of next-generation wireless electronics by enabling innovative companies to design products that minimize battery dependency, reduce overall power consumption, and enhance design flexibility. Additionally, Ambiq Micro provides technical support services to its clients, further contributing to its mission of advancing low-power semiconductor solutions.

Metanoia Communications (”Metanoia”) was established in Hsinchu Science Park, Taiwan in 2004. Metanoia develops semiconductor and software solutions to the Wireline broadband market and the in-home networking market, providing very high-speed PHY chipsets to the broadband manufacturers. Metanoia combines “state of the art” system architecture and algorithm expertise with extensive integrated circuit design capabilites to deliver a broad range of fixed line communication products for access and In-home applications. Their portfolio includes products for the xDSL markets (more specifically for the VDSL2 and the upcoming G.fast markets), and the G.hn market.

DSP Concepts Inc. specializes in the development of audio tools and intellectual property for audio-enabled products. The company is known for its flagship platform, Audio Weaver, which is a cross-platform audio processing engine that facilitates the creation and delivery of audio features for a variety of applications. DSP Concepts also offers TalkTo, a suite of machine learning algorithms designed to enhance microphone performance in challenging acoustic environments. Additionally, the company provides a software-based asynchronous sample rate converter and a range of design and consulting services, including automotive audio design, system architecture consultation, and custom protocol development. Its technologies are utilized in numerous automotive and consumer products, serving a diverse clientele that includes well-known brands in the automotive and smart home sectors. Founded in 2003 and headquartered in Santa Clara, California, DSP Concepts operates additional offices in Dedham, Massachusetts; Germany; and China.

Oculii develops advanced AI software for radar systems, aiming to enhance resolution, range, and accuracy while reducing costs compared to traditional solutions. Its technology is essential for the advancement of autonomous vehicles, which require reliable and high-performance perception capabilities in all weather conditions. By utilizing Virtual Aperture Imaging, Oculii's software allows existing radar hardware to achieve higher angular resolution without the need for increased physical antenna count. This innovation enables the extraction of detailed 4D positioning information from low-cost, off-the-shelf radar components, paving the way for improved radar imaging. Oculii collaborates with leading companies in autonomous vehicles, robotics, and drones, positioning itself as a key player in the development of affordable and effective perception technologies for the future of autonomy.

Oculii develops advanced AI software for radar systems, aiming to enhance resolution, range, and accuracy while reducing costs compared to traditional solutions. Its technology is essential for the advancement of autonomous vehicles, which require reliable and high-performance perception capabilities in all weather conditions. By utilizing Virtual Aperture Imaging, Oculii's software allows existing radar hardware to achieve higher angular resolution without the need for increased physical antenna count. This innovation enables the extraction of detailed 4D positioning information from low-cost, off-the-shelf radar components, paving the way for improved radar imaging. Oculii collaborates with leading companies in autonomous vehicles, robotics, and drones, positioning itself as a key player in the development of affordable and effective perception technologies for the future of autonomy.

Tripresso is an online travel agent based in Taipei, Taiwan, established in 2013. Initially, it focused on creating an online marketplace for package tour suppliers, such as Lions Travel and Richmond, while also developing a user-friendly search engine for customers to find suitable travel products. Over time, Tripresso expanded its offerings to include hotels, flight tickets, and customized travel plans for outbound travel. In 2018, the company introduced TripSaaS, a proprietary software-as-a-service system designed to assist traditional travel agencies in managing their websites, product listings, orders, and customer relationships, thereby improving operational efficiency. By leveraging data and partnerships from both online and offline sources, Tripresso aims to streamline travel planning and provide users with affordable travel packages.

Viracta Therapeutics, Inc. is a clinical-stage drug development company based in Cardiff, California, focused on precision oncology for virus-associated malignancies. The company specializes in a viral activation therapy platform aimed at treating cancers linked to the Epstein-Barr Virus (EBV) and other virus-associated diseases. Its lead investigational drug, nanatinostat, is being evaluated in combination with the antiviral valganciclovir in Phase 2 clinical trials for EBV-positive lymphoma, including conditions such as post-transplant lymphoproliferative disorder and plasmablastic lymphoma. Viracta is also exploring the application of this therapeutic approach in treating other EBV-related malignancies, such as nasopharyngeal carcinoma and gastric carcinoma. Founded in 2007 and previously known as HemaQuest Pharmaceuticals, Viracta Therapeutics continues to advance its mission to develop innovative treatments for serious viral-associated cancers.

Pavilion Data Systems Inc. is a technology company that specializes in designing and developing NVMe-over-Fabric storage platforms tailored for massively-parallel applications. Established in 2011 and headquartered in San Jose, California, with additional offices in the Netherlands and India, the company aims to enhance storage performance and efficiency for various sectors, including financial services, government, cloud service providers, and media and entertainment. Pavilion's innovative architecture offers a new category of storage solutions known as Hyperparallel Flash Arrays, which utilize multiple controllers to achieve ultra-low latency and linear scalability, surpassing the limitations of traditional all-flash arrays. The company's offerings include the Pavilion Data OS, which supports Internet and SaaS businesses in delivering critical applications, alongside its OPENCHOICE model that redefines storage procurement and deployment strategies. Through its advanced technology and experienced team, Pavilion Data Systems is positioned as a leader in the evolving landscape of enterprise storage solutions.

Light Field Lab is a breakthrough technology startup that builds an innovative holographic ecosystem. It re-creates what optical physics calls a real image for off-screen projected objects by generating a massive number of viewing angles that correctly change with the point of view and location just like in the real world. They enable entirely new business opportunities across consumer and enterprise markets. The company was founded in 2017 by Jon Karafin, Brendan Bevensee, and Ed Ibe, with the single mission to enable a holographic future by building upon the founders’ collective expertise of light field technology innovation. Based in San Jose, CA, Light Field Lab is backed by top-tier venture firms including Khosla Ventures.

Frequency Therapeutics is a clinical-stage biotechnology company based in Woburn, Massachusetts, that aims to repair or reverse damage from various degenerative diseases by utilizing the body’s own biological mechanisms. The company employs a Progenitor Cell Activation approach, which involves the use of small molecules to activate progenitor cells and promote the regeneration of functional tissue. Its leading product candidate, FX-322, is currently undergoing phase 2a clinical trials to address the underlying causes of sensorineural hearing loss. In addition to hearing loss, Frequency Therapeutics is also exploring treatments for a range of other conditions, including multiple sclerosis and diseases affecting muscle, the gastrointestinal tract, skin, and bone. The company has established a collaboration with Astellas Pharma for the development and commercialization of FX-322. Founded in 2014, Frequency Therapeutics focuses on disease modification without the complexities associated with genetic engineering.

Touché Solutions, previously known as Mechavision, specializes in the development of robotic technology platforms, particularly focusing on IoT sensor modules and smart manufacturing applications. The company manufactures robot sensor modules and offers advanced plug-in robot haptic technology products, which have been integrated into Qisda's human-machine collaboration production line. Through its commitment to research and development, Touché Solutions aims to enhance the efficiency of intelligent robotic development for its clients, thereby advancing the capabilities of robotics in various industrial applications.

Tricorntech specializes in semiconductor process control, environmental monitoring, and pollution detection. The company offers a range of services, including the detection of volatile organic compounds and rapid air quality analysis applicable in various settings, from cleanrooms to urban environments. Its product offerings focus on ensuring quality assurance in semiconductor processes, as well as monitoring groundwater and soil contamination. Tricorntech serves a diverse clientele across multiple sectors, including semiconductor manufacturing, steel production, petrochemicals, food processing, healthcare, and public environmental services.

Ambiq Micro, Inc. specializes in the development of ultra-low power integrated circuits tailored for power-sensitive applications. The company focuses on creating subthreshold power optimized technology, producing real-time clocks and microcontrollers for various uses, including wearables, smart cards, wireless sensors, and Internet-of-Things (IoT) devices. Founded in 2009 and based in Austin, Texas, Ambiq Micro also maintains offices in San Jose, California, and several locations in China. Its pioneering technology aims to facilitate the creation of next-generation wireless electronics by enabling innovative companies to design products that minimize battery dependency, reduce overall power consumption, and enhance design flexibility. Additionally, Ambiq Micro provides technical support services to its clients, further contributing to its mission of advancing low-power semiconductor solutions.

Frequency Therapeutics is a clinical-stage biotechnology company based in Woburn, Massachusetts, that aims to repair or reverse damage from various degenerative diseases by utilizing the body’s own biological mechanisms. The company employs a Progenitor Cell Activation approach, which involves the use of small molecules to activate progenitor cells and promote the regeneration of functional tissue. Its leading product candidate, FX-322, is currently undergoing phase 2a clinical trials to address the underlying causes of sensorineural hearing loss. In addition to hearing loss, Frequency Therapeutics is also exploring treatments for a range of other conditions, including multiple sclerosis and diseases affecting muscle, the gastrointestinal tract, skin, and bone. The company has established a collaboration with Astellas Pharma for the development and commercialization of FX-322. Founded in 2014, Frequency Therapeutics focuses on disease modification without the complexities associated with genetic engineering.